579 Rationale and design for the Kallikrein Inhibitor in Netherton Syndrome (KINS) pivotal clinical trial

K.W. Johnson, A. Hovnanian, J. Teng,A.S. Paller,K. Choate, P. Elias, Z. Laura,T. Nguyen,D. Smith,A. Hsu, L. Alani, C. Lai,L. Hsu

Journal of Investigative Dermatology(2020)

引用 0|浏览16
暂无评分
关键词
kallikrein inhibitor,netherton syndrome,clinical trial,pivotal clinical trial
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要